SCHEMBL27680946

SCHEMBL27680946

Ic1ccc(NC2CC2)nc1.Ic1ccc(NC2CC2)nc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 3/20 0.56
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
KCNQ3 O43525 1/20 0.41
KCNQ2 O43526 1/20 0.41
MALT1 Q9UDY8 2/20 0.39
PDE10A Q9Y233 1/20 0.38
PRKAB2 O43741 1/20 0.38
PRKAG1 P54619 1/20 0.38
PRKAA2 P54646 1/20 0.38
PRKAA1 Q13131 1/20 0.38
PRKAG3 Q9UGI9 1/20 0.38
PRKAG2 Q9UGJ0 1/20 0.38
PRKAB1 Q9Y478 1/20 0.38
TDO2 P48775 1/20 0.37
CCNK O75909 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CDK12 Q9NYV4 1/20 0.37
CCR6 P51684 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2709790 1.00 HCAR3 (0.56) HCAR3CYP11B1CYP11B2KCNQ3KCNQ2
SCHEMBL18307123 0.91 HCAR3 (0.57) HCAR3CYP11B1CYP11B2PDE10AALDH1A1
Trifluoroacetic Acid SCHEMBL2714193 0.86 HCAR3 (0.55) HCAR3KCNQ3KCNQ2MALT1CCR6
SCHEMBL27252079 0.85 HCAR3 (0.43) HCAR3CYP11B1CYP11B2
SCHEMBL27251863 0.85 HCAR3 (0.43) HCAR3CYP11B1CYP11B2
SCHEMBL29310695 0.85 HCAR3 (0.43) HCAR3CYP11B1CYP11B2KCNQ3KCNQ2
SCHEMBL30827678 0.85 HCAR3 (0.43) HCAR3CYP11B1CYP11B2
SCHEMBL27363570 0.85 SYK (0.45) HCAR3CCR6
SCHEMBL30825860 0.82 HCAR3 (0.41) HCAR3CYP11B1CYP11B2KCNQ3KCNQ2
SCHEMBL31456728 0.82 KDM4E (0.44) HCAR3CYP11B1CYP11B2CDK2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1930144-A 3-'4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases BOEHRINGER INGELHEIM PHARMA (US) 2007-03-14 CN disclosed